Prosecution Insights
Last updated: October 27, 2026

Bridget E Bunner, USPTO Patent Examiner

Listed by the USPTO as BUNNER, BRIDGET E

Tech Center 1600 • Art Units: 1644 1646 1647 1654 1674

This examiner grants 65% of resolved cases

Analysis

BUNNER, BRIDGET E works in technology center 1600 and art unit 1644. The record covers 844 resolved cases, with an allowance rate of 64.6%, an interview lift of 19.8%, and a median of 1044 days to allowance. The substantial docket provides a useful basis for planning, while the figures support combining careful written prosecution with interviews when claim scope or technical distinctions require clarification.

The listed companies are The Regents of the University of California, Hoffmann-La Roche Inc., and Novartis AG. The listed firms are MARSHALL, GERSTEIN & BORUN LLP, Baker Donelson, and Ballard Spahr LLP. Counsel handling university or pharmaceutical matters can use the profile to anticipate the docket context and to develop fallback positions around the reported examination period.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

64.6%
Allow Rate
+4.6% vs TC avg
890
Total Applications
+19.8%
Interview Lift
1044
Avg Prosecution Days
Based on 844 resolved cases, 2023–2026

Rejection Statute Breakdown

6.4%
§101 Eligibility
18.7%
§102 Novelty
15.5%
§103 Obviousness
38.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18034326 USE OF AN IL-18 ANTAGONIST FOR TREATING AND/OR PREVENTION OF ATOPIC DERMATITIS OR A RELATED CONDITION Non-Final OA NOVARTIS AG
18798981 ANTI-IL-36R ANTIBODIES FOR THE TREATMENT OF NEUTROPHILIC DERMATOSES Non-Final OA Boehringer Ingelheim International GmbH
18283575 METHODS AND AGENTS FOR MODULATING ADOPTIVE IMMUNOTHERAPY Non-Final OA The Regents of the University of California
18274979 IMMUNE RECEPTORS WITH SYNTHETIC CO-STIMULATORY DOMAINS Non-Final OA The Regents of the University of California
17877814 COMPOSITIONS COMPRISING EXTRACELLULAR VESICLES, SECRETED BIOMOLECULES, AND/OR CONDITIONED MEDIA, AND METHODS OF PRODUCING AND USING THE SAME Final Rejection L'Oreal

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Bridget E Bunner's allowance rate?

64.6% of resolved applications examined by Bridget E Bunner were allowed (844 resolved cases), compared with 35.9% across Art Unit 1644 over the last five years.

Does an interview help with examiner Bridget E Bunner?

This examiner's interview lift is +19.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Bridget E Bunner take to allow a patent?

Applications allowed by Bridget E Bunner took 1,044 days on average from filing to allowance.

Which art unit does examiner Bridget E Bunner work in?

Bridget E Bunner examines applications in Art Unit 1644 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month